Spanish pharmaceutical firm starts clinical trials for covid-19 treatment
Written by on April 1, 2020
A Spanish pharmaceutical company is beginning research and clinical trials using plasma from survivors of the virus in an effort to produce an inoculation against the virus.
In Depth: Coronavirus outbreak in Spain
Trials in Spain have already begun with hospitals and Grifols researching whether blood plasma is an effective method [icon name=”external-link” class=”” unprefixed_class=””] for treating the virus.
A final drug may be available by July.